Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity

Free Radical Biology and Medicine

Volumn 50, Issue 4, 2011, Pages 537-549

  Hašková, Pavlína ^a   Kovaříková, Petra ^a   Koubková, Lucie ^a   Vávrová, Anna ^a   MacKová, Eliška ^a   Šimůnek, Tomáš ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Aminochromes; Cardiotoxicity; Catecholamines; Epinephrine; Free radicals; Isoprenaline; Salicylaldehyde isonicotinoyl hydrazone

Indexed keywords

ADRENALIN; ADRENOCHROME; ASCORBIC ACID; CASPASE 8; CATECHOLAMINE; IRON; IRON CHELATING AGENT; ISOPRENALINE; REACTIVE OXYGEN METABOLITE; SALICYLALDEHYDE ISONICOTINOYL HYDRAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; AUTOOXIDATION; CARDIOTOXICITY; CELL DEATH; CELL STRUCTURE; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; EMBRYO; HEART MUSCLE CELL; HEART PROTECTION; INTRACELLULAR SPACE; IRON BINDING CAPACITY; IRON CHELATION; MYOBLAST; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT;

ALDEHYDES; ANIMALS; ASCORBIC ACID; BINDING, COMPETITIVE; CASPASES; CATECHOLAMINES; CELL LINE; CELL SURVIVAL; COORDINATION COMPLEXES; CYTOPROTECTION; ENZYME ASSAYS; HYDRAZONES; IRON; IRON CHELATING AGENTS; MYOBLASTS, CARDIAC; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES;

EID: 79251623137     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.12.004     Document Type: Article

References (66)

1. W.F. Ganong Review of Medical Physiology 2005 McGraw-Hill Medical New York/London
2. J.N. Cohn, T.B. Levine, M.T. Olivari, V. Garberg, D. Lura, G.S. Francis, A.B. Simon, and T. Rector Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N. Engl. J. Med. 311 1984 819 823
3. D.L. Mann, R.L. Kent, B. Parsons, and G.T. Cooper Adrenergic effects on the biology of the adult mammalian cardiocyte Circulation 85 1992 790 804
4. N.S. Dhalla, A. Adameova, and M. Kaur Role of catecholamine oxidation in sudden cardiac death Fundam. Clin. Pharmacol. 24 2010 539 546
5. P. Mladenka, R. Hrdina, Z. Bobrovova, V. Semecky, J. Vavrova, M. Holeckova, V. Palicka, Y. Mazurova, and P. Nachtigal Cardiac biomarkers in a model of acute catecholamine cardiotoxicity Hum. Exp. Toxicol. 28 2009 631 640
6. G. Rona, C.I. Chappel, T. Balazs, and R. Gaudry An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat AMA Arch. Pathol. 67 1959 443 455
7. M. Diaz-Munoz, M.A. Alvarez-Perez, L. Yanez, S. Vidrio, L. Martinez, G. Rosas, M. Yanez, S. Ramirez, and V.C. de Sanchez Correlation between oxidative stress and alteration of intracellular calcium handling in isoproterenol-induced myocardial infarction Mol. Cell. Biochem. 289 2006 125 136
8. A. Fleckenstein, J. Janke, H.J. Doring, and O. Leder Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology Recent Adv. Stud. Card. Struct. Metab. 4 1974 563 580
9. M. Persoon-Rothert, E.J. van der Valk-Kokshoorn, J.M. Egas-Kenniphaas, I. Mauve, and A. van der Laarse Isoproterenol-induced cytotoxicity in neonatal rat heart cell cultures is mediated by free radical formation J. Mol. Cell. Cardiol. 21 1989 1285 1291
10. P.K. Singal, R.E. Beamish, and N.S. Dhalla Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease Adv. Exp. Med. Biol. 161 1983 391 401
11. 2+-induced isoproterenol oxidation into isoprenochrome in adult rat calcium-tolerant cardiomyocytes Chem. Res. Toxicol. 15 2002 861 869
12. R. Silva, S. Boldt, V.M. Costa, H. Carmo, M. Carvalho, F. Carvalho, L. Bastos Mde, F. Lemos-Amado, and F. Remiao Evaluation of GSH adducts of adrenaline in biological samples Biomed. Chromatogr. 21 2007 670 679
13. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine 2007 Oxford Univ. Press Oxford/New York
14. P. Mladenka, T. Simunek, M. Hubl, and R. Hrdina The role of reactive oxygen and nitrogen species in cellular iron metabolism Free Radic. Res. 40 2006 263 272
15. D.W. Reif Ferritin as a source of iron for oxidative damage Free Radic. Biol. Med. 12 1992 417 427
16. A. Voogd, W. Sluiter, H.G. van Eijk, and J.F. Koster Low molecular weight iron and the oxygen paradox in isolated rat hearts J. Clin. Invest. 90 1992 2050 2055
17. A. Terman, and U.T. Brunk Oxidative stress, accumulation of biological 'garbage', and aging Antioxid. Redox Signaling 8 2006 197 204
18. D.S. Kalinowski, and D.R. Richardson The evolution of iron chelators for the treatment of iron overload disease and cancer Pharmacol. Rev. 57 2005 547 583
19. N.F. Olivieri, and G.M. Brittenham Iron-chelating therapy and the treatment of thalassemia Blood 89 1997 739 761
20. J.C. Wood Cardiac iron across different transfusion-dependent diseases Blood Rev. 22 Suppl. 2 2008 S14 S21
21. J.B. Galey Recent advances in the design of iron chelators against oxidative damage Mini Rev. Med. Chem. 1 2001 233 242
22. B.B. Hasinoff, K. Hellmann, E.H. Herman, and V.J. Ferrans Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines Curr. Med. Chem. 5 1998 1 28
23. C. Flandina, R. Sanguedolce, L. Rausa, and N. D'Alessandro Ameliorative effects of ICRF-187 [(+)-1, 2-bis(3, 5-dioxopiperazinyl-1-yl)propane] on the cardiotoxicity induced by doxorubicin or by isoproterenol in the mouse Res. Commun. Chem. Pathol. Pharmacol. 70 1990 259 272
24. P. Bendova, E. Mackova, P. Haskova, A. Vavrova, E. Jirkovsky, M. Sterba, O. Popelova, D.S. Kalinowski, P. Kovarikova, K. Vavrova, D.R. Richardson, and T. Simunek Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury Chem. Res. Toxicol. 23 2010 1105 1114
25. T. Kurz, B. Gustafsson, and U.T. Brunk Intralysosomal iron chelation protects against oxidative stress-induced cellular damage FEBS J. 273 2006 3106 3117
26. N. Lukinova, J. Iacovelli, T. Dentchev, N. Wolkow, A. Hunter, D. Amado, G.S. Ying, J.R. Sparrow, and J.L. Dunaief Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli Invest. Ophthalmol. Vis. Sci. 50 2009 1440 1447
27. T. Simunek, C. Boer, R.A. Bouwman, R. Vlasblom, A.M. Versteilen, M. Sterba, V. Gersl, R. Hrdina, P. Ponka, J.J. de Lange, W.J. Paulus, and R.J. Musters SIH-a novel lipophilic iron chelator-protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death J. Mol. Cell. Cardiol. 39 2005 345 354
28. I. Klimtova, T. Simunek, Y. Mazurova, J. Kaplanova, M. Sterba, R. Hrdina, V. Gersl, M. Adamcova, and P. Ponka A study of potential toxic effects after repeated 10-week administration of a new iron chelator-salicylaldehyde isonicotinoyl hydrazone (SIH) to rabbits Acta Med. (Hradec Kralove) 46 2003 163 170
29. J.T. Edward, M. Gauthier, F.L. Chubb, and P. Ponka Synthesis of new acylhydrazones as iron-chelating compounds J. Chem. Eng. Data 33 1988 538 540
30. B.P. Esposito, S. Epsztejn, W. Breuer, and Z.I. Cabantchik A review of fluorescence methods for assessing labile iron in cells and biological fluids Anal. Biochem. 304 2002 1 18
31. R.T. Dean, and P. Nicholson The action of nine chelators on iron-dependent radical damage Free Radic. Res. 20 1994 83 101
32. P. Mladenka, D.S. Kalinowski, P. Haskova, Z. Bobrovova, R. Hrdina, T. Simunek, P. Nachtigal, V. Semecky, J. Vavrova, M. Holeckova, V. Palicka, Y. Mazurova, P.J. Jansson, and D.R. Richardson The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity Chem. Res. Toxicol. 22 2009 208 217
33. B.W. Kimes, and B.L. Brandt Properties of a clonal muscle cell line from rat heart Exp. Cell Res. 98 1976 367 381
34. G. Repetto, A. del Peso, and J.L. Zurita Neutral red uptake assay for the estimation of cell viability/cytotoxicity Nat. Protoc. 3 2008 1125 1131
35. C. Kohler, S. Orrenius, and B. Zhivotovsky Evaluation of caspase activity in apoptotic cells J. Immunol. Meth. 265 2002 97 110
36. H. Wang, and J.A. Joseph Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader Free Radic. Biol. Med. 27 1999 612 616
37. H.P. Misra, and I. Fridovich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J. Biol. Chem. 247 1972 3170 3175
38. L.M. Garrick, K. Gniecko, J.E. Hoke, A. al-Nakeeb, P. Ponka, and M.D. Garrick Ferric-salicylaldehyde isonicotinoyl hydrazone, a synthetic iron chelate, alleviates defective iron utilization by reticulocytes of the Belgrade rat J. Cell. Physiol. 146 1991 460 465
39. X. Chen, Z. Zhong, Z. Xu, L. Chen, and Y. Wang 2′, 7′-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy Free Radic. Res. 44 2010 587 604
40. M. Karlsson, T. Kurz, U.T. Brunk, S.E. Nilsson, and C.I. Frennesson What does the commonly used DCF test for oxidative stress really show? Biochem. J. 428 2010 183 190
41. M. Wrona, K.B. Patel, and P. Wardman The roles of thiol-derived radicals in the use of 2′, 7′-dichlorodihydrofluorescein as a probe for oxidative stress Free Radic. Biol. Med. 44 2008 56 62
42. M. Wrona, and P. Wardman Properties of the radical intermediate obtained on oxidation of 2′, 7′-dichlorodihydrofluorescein, a probe for oxidative stress Free Radic. Biol. Med. 41 2006 657 667
43. J.C. Yates, and N.S. Dhalla Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol J. Mol. Cell. Cardiol. 7 1975 807 816
44. A. Bindoli, M.P. Rigobello, and D.J. Deeble Biochemical and toxicological properties of the oxidation products of catecholamines Free Radic. Biol. Med. 13 1992 391 405
45. A. Bindoli, M.P. Rigobello, and L. Galzigna Toxicity of aminochromes Toxicol. Lett. 48 1989 3 20
46. S. Bharath, M. Hsu, D. Kaur, S. Rajagopalan, and J.K. Andersen Glutathione, iron and Parkinson's disease Biochem. Pharmacol. 64 2002 1037 1048
47. G.S. Behonick, M.J. Novak, E.W. Nealley, and S.I. Baskin Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes) J. Appl. Toxicol. 21 Suppl. 1 2001 S15 S22
48. V.M. Costa, R. Silva, L.M. Ferreira, P.S. Branco, F. Carvalho, M.L. Bastos, R.A. Carvalho, M. Carvalho, and F. Remiao Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: formation of adrenochrome, quinoproteins, and GSH adduct Chem. Res. Toxicol. 20 2007 1183 1191
49. S. Melmed, and P.M. Conn Endocrinology: Basic and Clinical Principles 2005 Humana Press Totowa, NJ
50. D.S. Goldstein, G. Eisenhofer, and I.J. Kopin Sources and significance of plasma levels of catechols and their metabolites in humans J. Pharmacol. Exp. Ther. 305 2003 800 811
51. T.W. Lameris, S. de Zeeuw, G. Alberts, F. Boomsma, D.J. Duncker, P.D. Verdouw, A.J. Veld, and A.H. van Den Meiracker Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo Circulation 101 2000 2645 2650
52. E.A. Gerlo, and C. Sevens Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases Clin. Chem. 40 1994 250 256
53. P.K. Singal, J.C. Yates, R.E. Beamish, and N.S. Dhalla Influence of reducing agents on adrenochrome-induced changes in the heart Arch. Pathol. Lab. Med. 105 1981 664 669
54. M.E. Gotz, K. Double, M. Gerlach, M.B. Youdim, and P. Riederer The relevance of iron in the pathogenesis of Parkinson's disease Ann. NY Acad. Sci. 1012 2004 193 208
55. D. Kaur, and J. Andersen Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res. Rev. 3 2004 327 343
56. D. Ben-Shachar, G. Eshel, J.P. Finberg, and M.B. Youdim The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons J. Neurochem. 56 1991 1441 1444
57. M.B. Youdim, G. Stephenson, and D. Ben Shachar Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28 Ann. NY Acad. Sci. 1012 2004 306 325
58. 2 injury in adult cardiomyocytes Cardiovasc. Res. 47 2000 529 536
59. T. Simunek, M. Sterba, O. Popelova, H. Kaiserova, M. Adamcova, M. Hroch, P. Haskova, P. Ponka, and V. Gersl Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone Br. J. Pharmacol. 155 2008 138 148
60. M. Sterba, O. Popelova, T. Simunek, Y. Mazurova, A. Potacova, M. Adamcova, I. Guncova, H. Kaiserova, V. Palicka, P. Ponka, and V. Gersl Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH) Toxicology 235 2007 150 166
61. D. Ben-Shachar, R. Zuk, and Y. Glinka Dopamine neurotoxicity: inhibition of mitochondrial respiration J. Neurochem. 64 1995 718 723
62. V.M. Costa, R. Silva, R. Ferreira, F. Amado, F. Carvalho, M. de Lourdes Bastos, R.A. Carvalho, M. Carvalho, and F. Remiao Adrenaline in pro-oxidant conditions elicits intracellular survival pathways in isolated rat cardiomyocytes Toxicology 257 2009 70 79
63. V.M. Costa, R. Silva, L.C. Tavares, R. Vitorino, F. Amado, F. Carvalho, L. Bastos Mde, M. Carvalho, R.A. Carvalho, and F. Remiao Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes Toxicology 260 2009 84 96
64. C. Communal, K. Singh, D.B. Sawyer, and W.S. Colucci Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein Circulation 100 1999 2210 2212
65. M. Koc, Z. Nad'ova, J. Truksa, M. Ehrlichova, and J. Kovar Iron deprivation induces apoptosis via mitochondrial changes related to Bax translocation Apoptosis 10 2005 381 393
66. Goldspink, D.F.; Burniston, J.G.; Ellison, G.M.; Clark, W.A.; Tan, L.B. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp. Physiol. 89:407-416; 2004.